135 related articles for article (PubMed ID: 18544529)
1. Modulation of double-stranded RNA recognition by the N-terminal histidine-rich region of the human toll-like receptor 3.
Fukuda K; Watanabe T; Tokisue T; Tsujita T; Nishikawa S; Hasegawa T; Seya T; Matsumoto M
J Biol Chem; 2008 Aug; 283(33):22787-94. PubMed ID: 18544529
[TBL] [Abstract][Full Text] [Related]
2. N-terminal binding site in the human toll-like receptor 3 ectodomain.
Watanabe T; Tokisue T; Tsujita T; Matsumoto M; Seya T; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2007; (51):405-6. PubMed ID: 18029758
[TBL] [Abstract][Full Text] [Related]
3. Significance of the N-terminal histidine-rich region for the function of the human toll-like receptor 3 ectodomain.
Tokisue T; Watanabe T; Tsujita T; Nishikawa S; Hasegawa T; Seya T; Matsumoto M; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2008; (52):203-4. PubMed ID: 18776324
[TBL] [Abstract][Full Text] [Related]
4. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH.
de Bouteiller O; Merck E; Hasan UA; Hubac S; Benguigui B; Trinchieri G; Bates EE; Caux C
J Biol Chem; 2005 Nov; 280(46):38133-45. PubMed ID: 16144834
[TBL] [Abstract][Full Text] [Related]
5. The dsRNA binding site of human Toll-like receptor 3.
Bell JK; Askins J; Hall PR; Davies DR; Segal DM
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8792-7. PubMed ID: 16720699
[TBL] [Abstract][Full Text] [Related]
6. The molecular structure of the TLR3 extracellular domain.
Bell JK; Botos I; Hall PR; Askins J; Shiloach J; Davies DR; Segal DM
J Endotoxin Res; 2006; 12(6):375-8. PubMed ID: 17254392
[TBL] [Abstract][Full Text] [Related]
7. Understanding the distinguishable structural and functional features in zebrafish TLR3 and TLR22, and their binding modes with fish dsRNA viruses: an exploratory structural model analysis.
Sahoo BR; Dikhit MR; Bhoi GK; Maharana J; Lenka SK; Dubey PK; Tiwari DK
Amino Acids; 2015 Feb; 47(2):381-400. PubMed ID: 25488424
[TBL] [Abstract][Full Text] [Related]
8. Insights into the dynamic nature of the dsRNA-bound TLR3 complex.
Gosu V; Son S; Shin D; Song KD
Sci Rep; 2019 Mar; 9(1):3652. PubMed ID: 30842554
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the interaction between human TLR3 ectodomain and nucleic acids.
Fukuda K; Tsujita T; Matsumoto M; Seya T; Sakiyama H; Nishikawa F; Nishikawa S; Hasegawa T
Nucleic Acids Symp Ser (Oxf); 2006; (50):249-50. PubMed ID: 17150911
[TBL] [Abstract][Full Text] [Related]
10. C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission.
Takada E; Okahira S; Sasai M; Funami K; Seya T; Matsumoto M
Mol Immunol; 2007 Jul; 44(15):3633-40. PubMed ID: 17521732
[TBL] [Abstract][Full Text] [Related]
11. Lateral clustering of TLR3:dsRNA signaling units revealed by TLR3ecd:3Fabs quaternary structure.
Luo J; Obmolova G; Malia TJ; Wu SJ; Duffy KE; Marion JD; Bell JK; Ge P; Zhou ZH; Teplyakov A; Zhao Y; Lamb RJ; Jordan JL; San Mateo LR; Sweet RW; Gilliland GL
J Mol Biol; 2012 Aug; 421(1):112-24. PubMed ID: 22579623
[TBL] [Abstract][Full Text] [Related]
12. The toll-like receptor 3:dsRNA signaling complex.
Botos I; Liu L; Wang Y; Segal DM; Davies DR
Biochim Biophys Acta; 2009; 1789(9-10):667-74. PubMed ID: 19595807
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of toll-like receptor 3 signaling with double-stranded RNA.
Liu L; Botos I; Wang Y; Leonard JN; Shiloach J; Segal DM; Davies DR
Science; 2008 Apr; 320(5874):379-81. PubMed ID: 18420935
[TBL] [Abstract][Full Text] [Related]
14. The TLR3 signaling complex forms by cooperative receptor dimerization.
Leonard JN; Ghirlando R; Askins J; Bell JK; Margulies DH; Davies DR; Segal DM
Proc Natl Acad Sci U S A; 2008 Jan; 105(1):258-63. PubMed ID: 18172197
[TBL] [Abstract][Full Text] [Related]
15. The molecular structure of the Toll-like receptor 3 ligand-binding domain.
Bell JK; Botos I; Hall PR; Askins J; Shiloach J; Segal DM; Davies DR
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10976-80. PubMed ID: 16043704
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the Role of
Wang Y; Wu S; Zhang C; Jin Y; Wang X
J Chem Inf Model; 2022 Nov; 62(21):5258-5266. PubMed ID: 34494836
[TBL] [Abstract][Full Text] [Related]
17. Crystallinity of Double-Stranded RNA-Antimicrobial Peptide Complexes Modulates Toll-Like Receptor 3-Mediated Inflammation.
Lee EY; Takahashi T; Curk T; Dobnikar J; Gallo RL; Wong GCL
ACS Nano; 2017 Dec; 11(12):12145-12155. PubMed ID: 29016111
[TBL] [Abstract][Full Text] [Related]
18. Dimerization of Toll-like receptor 3 (TLR3) is required for ligand binding.
Wang Y; Liu L; Davies DR; Segal DM
J Biol Chem; 2010 Nov; 285(47):36836-41. PubMed ID: 20861016
[TBL] [Abstract][Full Text] [Related]
19. LL-37 peptide enhancement of signal transduction by Toll-like receptor 3 is regulated by pH: identification of a peptide antagonist of LL-37.
Singh D; Vaughan R; Kao CC
J Biol Chem; 2014 Oct; 289(40):27614-24. PubMed ID: 25092290
[TBL] [Abstract][Full Text] [Related]
20. Isolation of RNA aptamers against human Toll-like receptor 3 ectodomain.
Watanabe T; Ito K; Matsumoto M; Seya T; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2006; (50):251-2. PubMed ID: 17150912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
